Annual EBITDA
$111.64 M
+$8.75 M+8.50%
December 31, 2023
Summary
- As of February 12, 2025, GMRE annual EBITDA is $111.64 million, with the most recent change of +$8.75 million (+8.50%) on December 31, 2023.
- During the last 3 years, GMRE annual EBITDA has risen by +$58.64 million (+110.64%).
- GMRE annual EBITDA is now at all-time high.
Performance
GMRE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$24.45 M
+$5.26 M+27.45%
September 30, 2024
Summary
- As of February 12, 2025, GMRE quarterly EBITDA is $24.45 million, with the most recent change of +$5.26 million (+27.45%) on September 30, 2024.
- Over the past year, GMRE quarterly EBITDA has dropped by -$1.93 million (-7.31%).
- GMRE quarterly EBITDA is now -35.16% below its all-time high of $37.71 million, reached on June 30, 2023.
Performance
GMRE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$89.01 M
-$1.93 M-2.12%
September 30, 2024
Summary
- As of February 12, 2025, GMRE TTM EBITDA is $89.01 million, with the most recent change of -$1.93 million (-2.12%) on September 30, 2024.
- Over the past year, GMRE TTM EBITDA has dropped by -$25.95 million (-22.57%).
- GMRE TTM EBITDA is now -25.94% below its all-time high of $120.19 million, reached on June 30, 2023.
Performance
GMRE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GMRE EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +8.5% | -7.3% | -22.6% |
3 y3 years | +110.6% | -3.3% | -13.5% |
5 y5 years | +135.1% | -3.3% | -13.5% |
GMRE EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +30.8% | -35.2% | +27.4% | -25.9% | +4.3% |
5 y | 5-year | at high | +112.3% | -35.2% | +404.0% | -25.9% | +76.7% |
alltime | all time | at high | >+9999.0% | -35.2% | +5941.6% | -25.9% | >+9999.0% |
Global Medical REIT EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $24.45 M(+27.4%) | $89.01 M(-2.1%) |
Jun 2024 | - | $19.18 M(-18.1%) | $90.94 M(-16.9%) |
Mar 2024 | - | $23.43 M(+6.7%) | $109.47 M(-1.9%) |
Dec 2023 | $111.64 M(+8.5%) | $21.95 M(-16.8%) | $111.64 M(-2.9%) |
Sep 2023 | - | $26.38 M(-30.0%) | $114.96 M(-4.4%) |
Jun 2023 | - | $37.71 M(+47.3%) | $120.19 M(+13.3%) |
Mar 2023 | - | $25.60 M(+1.3%) | $106.05 M(+3.1%) |
Dec 2022 | $102.89 M(+20.6%) | $25.27 M(-20.0%) | $102.89 M(+2.1%) |
Sep 2022 | - | $31.61 M(+34.1%) | $100.74 M(+10.2%) |
Jun 2022 | - | $23.56 M(+5.0%) | $91.43 M(+3.3%) |
Mar 2022 | - | $22.44 M(-3.0%) | $88.54 M(+3.7%) |
Dec 2021 | $85.35 M(+61.0%) | $23.13 M(+3.8%) | $85.35 M(+6.7%) |
Sep 2021 | - | $22.29 M(+7.8%) | $80.02 M(+27.9%) |
Jun 2021 | - | $20.67 M(+7.4%) | $62.58 M(+9.7%) |
Mar 2021 | - | $19.25 M(+8.1%) | $57.05 M(+7.6%) |
Dec 2020 | $53.00 M(+0.8%) | $17.81 M(+267.1%) | $53.00 M(+5.2%) |
Sep 2020 | - | $4.85 M(-68.0%) | $50.38 M(-14.8%) |
Jun 2020 | - | $15.14 M(-0.4%) | $59.12 M(+4.4%) |
Mar 2020 | - | $15.20 M(+0.1%) | $56.62 M(+7.7%) |
Dec 2019 | $52.58 M(+10.7%) | $15.18 M(+11.7%) | $52.58 M(-6.2%) |
Sep 2019 | - | $13.59 M(+7.5%) | $56.05 M(+5.7%) |
Jun 2019 | - | $12.64 M(+13.3%) | $53.05 M(+5.5%) |
Mar 2019 | - | $11.16 M(-40.2%) | $50.28 M(+5.9%) |
Dec 2018 | $47.49 M | $18.66 M(+76.3%) | $47.49 M(+33.2%) |
Sep 2018 | - | $10.59 M(+7.2%) | $35.67 M(+16.6%) |
Jun 2018 | - | $9.88 M(+18.0%) | $30.59 M(+25.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2018 | - | $8.37 M(+22.4%) | $24.38 M(+39.4%) |
Dec 2017 | $17.48 M(>+9900.0%) | $6.83 M(+24.2%) | $17.49 M(+70.3%) |
Sep 2017 | - | $5.50 M(+49.7%) | $10.27 M(+132.4%) |
Jun 2017 | - | $3.68 M(+149.8%) | $4.42 M(+115.2%) |
Mar 2017 | - | $1.47 M(-482.5%) | $2.05 M(+1160.5%) |
Dec 2016 | $163.00 K(-71.4%) | -$384.80 K(+11.1%) | $162.90 K(-67.5%) |
Sep 2016 | - | -$346.20 K(-126.4%) | $501.20 K(-42.2%) |
Jun 2016 | - | $1.31 M(-413.6%) | $866.70 K(-654.5%) |
Mar 2016 | - | -$418.50 K(+800.0%) | -$156.30 K(-127.4%) |
Dec 2015 | $570.00 K(+132.4%) | -$46.50 K(-340.9%) | $570.00 K(-30.3%) |
Sep 2015 | - | $19.30 K(-93.3%) | $818.20 K(+72.8%) |
Jun 2015 | - | $289.40 K(-6.0%) | $473.60 K(+167.1%) |
Mar 2015 | - | $307.80 K(+52.6%) | $177.30 K(-223.0%) |
Dec 2014 | $245.30 K(-209.3%) | - | - |
Nov 2014 | - | $201.70 K(-162.0%) | -$144.20 K(-59.2%) |
Aug 2014 | -$224.50 K(+395.6%) | -$325.30 K(+4614.5%) | -$353.60 K(+1149.5%) |
May 2014 | - | -$6900.00(-49.6%) | -$28.30 K(+1.4%) |
Feb 2014 | - | -$13.70 K(+77.9%) | -$27.90 K(+56.7%) |
Nov 2013 | - | -$7700.00(+18.5%) | -$17.80 K(-67.2%) |
Aug 2013 | -$45.30 K(-9.6%) | - | - |
May 2013 | - | -$6500.00(+80.6%) | -$54.30 K(-26.2%) |
Feb 2013 | - | -$3600.00(-87.0%) | -$73.60 K(+5.0%) |
Nov 2012 | - | -$27.60 K(+66.3%) | -$70.10 K(+39.9%) |
Aug 2012 | -$50.10 K | -$16.60 K(-35.7%) | -$50.10 K(+49.6%) |
May 2012 | - | -$25.80 K(>+9900.0%) | -$33.50 K(+335.1%) |
Feb 2012 | - | -$100.00(-98.7%) | -$7700.00(+1.3%) |
Nov 2011 | - | -$7600.00 | -$7600.00 |
FAQ
- What is Global Medical REIT annual EBITDA?
- What is the all time high annual EBITDA for Global Medical REIT?
- What is Global Medical REIT annual EBITDA year-on-year change?
- What is Global Medical REIT quarterly EBITDA?
- What is the all time high quarterly EBITDA for Global Medical REIT?
- What is Global Medical REIT quarterly EBITDA year-on-year change?
- What is Global Medical REIT TTM EBITDA?
- What is the all time high TTM EBITDA for Global Medical REIT?
- What is Global Medical REIT TTM EBITDA year-on-year change?
What is Global Medical REIT annual EBITDA?
The current annual EBITDA of GMRE is $111.64 M
What is the all time high annual EBITDA for Global Medical REIT?
Global Medical REIT all-time high annual EBITDA is $111.64 M
What is Global Medical REIT annual EBITDA year-on-year change?
Over the past year, GMRE annual EBITDA has changed by +$8.75 M (+8.50%)
What is Global Medical REIT quarterly EBITDA?
The current quarterly EBITDA of GMRE is $24.45 M
What is the all time high quarterly EBITDA for Global Medical REIT?
Global Medical REIT all-time high quarterly EBITDA is $37.71 M
What is Global Medical REIT quarterly EBITDA year-on-year change?
Over the past year, GMRE quarterly EBITDA has changed by -$1.93 M (-7.31%)
What is Global Medical REIT TTM EBITDA?
The current TTM EBITDA of GMRE is $89.01 M
What is the all time high TTM EBITDA for Global Medical REIT?
Global Medical REIT all-time high TTM EBITDA is $120.19 M
What is Global Medical REIT TTM EBITDA year-on-year change?
Over the past year, GMRE TTM EBITDA has changed by -$25.95 M (-22.57%)